USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
28-Oct-2005
Global
Market Research
F404-01-00-00-00
HC01452-GL-MR_05946
The Global Cancer Therapeutics Market is a fast growing market that is relying heavily on new drugs. The total therapeutic market is expected to grow from $23.1 billion in 2004 to $60.6 billion in 2011. The targeted therapy segment is providing the growth of the entire market with an expected compound annual growth rate of 24.1 percent for 2004-2011.
Introduction
- Introduction
- Disclaimer
- Certification
- Contents
- Top 15 Growth Cancer Therapeutics
Market Overview
- Contents
- Research Scope and Methodology
- Abreviations
- Segmentation
- Targeted Therapy Segments
- Targeted Therapy Definitions
- Summary of Findings
- Market Drivers (1)
- Market Drivers (2)
- Challenges and Strategies (1)
- Challenges and Strategies (2)
- Challenges and Strategies (3)
- Challenges and Strategies (4)
- Challenges and Strategies (5)
Total Market Forecasts
- Contents
- Total Market Forecasts
- Total Market Forecasts by Therapeutic Class
- US Forecasts by Therapeutic Class
- Ex US Forecasts by Therapeutic Class
- Cytotoxic Therapy Forecasts
- Hormone Therapy Forecasts
- Targeted Therapy Forecasts
- Global Market Share Analysis
- US Market Share Analysis
- Ex US Market Share Analysis
NSCLC
- Contents
- Disease Overview
- Epidemiology Trends
- Incidence
- Mortality
- Treatment Overview
- Common Drugs
- Common Regimens
- Treatment Diagram
- Revenue Forecasts
- Drug Development
Breast Cancer
- Contents
- Disease Overview
- Epidemiology
- Incidence
- Mortality
- Treatment Overview
- Common Drugs
- Common Regimens
- Hormone Treatment Diagram
- Metastatic Treatment Diagram
- Revenue Forecasts
- Drug Development
Colorectal Cancer
- Contents
- Disease Overview
- Epidemiology
- Incidence
- Mortality
- Treatment Overview
- Common Drugs
- Common Regimens
- Treatment Diagram
- Revenue Forecasts
- Drug Development
Prostate Cancer
- Contents
- Disease Overview
- Epidemiology
- Incidence
- Mortality
- Treatment Overview
- Common Drugs
- Common Regimens
- Treatment Diagram
- Revenue Forecasts
- Drug Development
Top 15 Growth Therapeutic Cancer Drugs (Overview; Indications Development and Forecasts)
- Contents
- Top 15 Growth Therapeutic Cancer Drugs
- Rituxan/MabThera
- Taxotere
- Gleevec/Glivec
- Eloxatin
- Gemzar
- Herceptin
- Zometa
- Casodex
- Arimidex
- Avastin
- Camptosar/Campto
- Temodar/Temodal
- Xeloda
- Femara
- Erbitux
Recent Filings and Approvals
- Contents
- Recent Filings and Approvals
Key Late-Stage Pipeline Drugs
- Contents
- Key Late-Stage Pipeline Drugs
Awards
- Contents
- Frost & Sullivan Awards
- Company of the Year
- Product Innovation of the Year
- Product-Line/Pipeline Strategy of the Year
- Entrepreneurial Company of the Year
- Business Development Strategy of the Year
Frost & Sullivan Capabilities
- Contents
- Our Capabilities I
- Our Capabilities II
- Our Consulting Clients
- Growth Consulting
- Growth Consulting Process
- Growth Consulting Deliverables
- Growth Partnership Service
- Growth Partnership Services Platform
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
28 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
26 Aug 2026 | Global | Technology Research
Growth Opportunities and Advancements in Acute and Chronic Wound Care
A wound is any disruption in the normal structure and function of the skin or underlying tissues. It can result from physical injury, surgery, or underlying medical conditions. Wounds are broadly classified into two categories: acute wounds and chronic wounds. Acute wounds typically heal through the...
26 Aug 2026 | Global | Frost Radar
Frost Radar™: Healthcare Infrastructure Cybersecurity in the United States, 2026
Healthcare organizations are expanding their digital environments across cloud infrastructure, connected medical devices, applications, identities, operational technology, and distributed care settings, creating a broader and increasingly interconnected attack surface. Cybersecurity is, therefore, e...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | F404-01-00-00-00 |
| Is Prebook | No |
Global Cancer Therapeutics Market Outlook
$4,950.00
Special Price $3,712.50 save 25 %